• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

改良纤维蛋白溶解疗法治疗机械性主动脉瓣血栓形成。

Modified fibrinolytic therapy as treatment of mechanical aortic valve thrombosis.

作者信息

Mustafa Ala, Thomas Todd, Murdock Robert, Congello Samuel

机构信息

Internal Medicine Department, MercyOne North Iowa Medical Center, Mason City, IA, USA.

Cardiology Department, MercyOne North Iowa Medical Center, Mason City, IA, USA.

出版信息

SAGE Open Med Case Rep. 2021 Mar 17;9:2050313X21999202. doi: 10.1177/2050313X21999202. eCollection 2021.

DOI:10.1177/2050313X21999202
PMID:33796313
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7975491/
Abstract

Prosthetic valve thrombosis is a rare phenomenon with limited treatment options. Current management choices include anticoagulation with or without fibrinolysis or surgical valve replacement for appropriate candidates. We report an alternative fibrinolytic and anticoagulation regimen resulting in successful treatment of a patient presenting with mechanical aortic valve thrombosis.

摘要

人工瓣膜血栓形成是一种罕见现象，治疗选择有限。目前的治疗选择包括抗凝治疗（可联合或不联合纤维蛋白溶解治疗），或为合适的患者进行外科瓣膜置换。我们报告了一种替代性的纤维蛋白溶解和抗凝方案，该方案成功治疗了一名患有机械性主动脉瓣血栓形成的患者。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d926/7975491/6acc98b096e1/10.1177_2050313X21999202-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d926/7975491/d6b8a2078d01/10.1177_2050313X21999202-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d926/7975491/5b19449bae13/10.1177_2050313X21999202-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d926/7975491/1ca80ac5cfcf/10.1177_2050313X21999202-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d926/7975491/6acc98b096e1/10.1177_2050313X21999202-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d926/7975491/d6b8a2078d01/10.1177_2050313X21999202-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d926/7975491/5b19449bae13/10.1177_2050313X21999202-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d926/7975491/1ca80ac5cfcf/10.1177_2050313X21999202-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d926/7975491/6acc98b096e1/10.1177_2050313X21999202-fig4.jpg

相似文献

1
Modified fibrinolytic therapy as treatment of mechanical aortic valve thrombosis.改良纤维蛋白溶解疗法治疗机械性主动脉瓣血栓形成。
SAGE Open Med Case Rep. 2021 Mar 17;9:2050313X21999202. doi: 10.1177/2050313X21999202. eCollection 2021.
2
Conservative management of a prosthetic valve thrombosis--report of a successful case.人工瓣膜血栓形成的保守治疗——1例成功病例报告
Heart Lung Circ. 2014 Oct;23(10):e207-9. doi: 10.1016/j.hlc.2014.04.257. Epub 2014 May 28.
3
Successful application of thrombolysis and angioplasty in case of mechanical aortic valve and coronary graft thrombosis.机械主动脉瓣和冠状动脉移植物血栓形成时溶栓和血管成形术的成功应用。
Acta Med Litu. 2016;23(1):1-4. doi: 10.6001/actamedica.v23i1.3263.
4
Successful fibrinolytic treatment in an old patient with acute aortic prosthetic thrombosis.老年急性人工主动脉瓣血栓形成患者的成功溶栓治疗
Eur J Echocardiogr. 2008 Jul;9(4):581-3. doi: 10.1093/ejechocard/jen072. Epub 2008 Feb 13.
5
Successful fibrinolytic treatment for recurrent thrombosis on aortic valve prosthesis.主动脉瓣人工瓣膜复发性血栓形成的成功纤溶治疗。
Jpn J Med. 1988 May;27(2):200-2. doi: 10.2169/internalmedicine1962.27.200.
6
Clinical Outcomes of Mechanical Prosthetic Valve Thrombosis.机械人工瓣膜血栓形成的临床结果
Cureus. 2020 Jun 22;12(6):e8760. doi: 10.7759/cureus.8760.
7
Mechanical cardiac valve thrombosis. Is fibrinolysis justified?机械性心脏瓣膜血栓形成。纤维蛋白溶解是否合理？
Circulation. 1992 Nov;86(5 Suppl):II8-15.
8
Low-Dose Alteplase Infusion for the Treatment of Mechanical Aortic Valve Thrombosis: A Spotlight on the Importance of Medication Adherence.小剂量阿替普酶输注治疗机械主动脉瓣血栓形成：关注药物依从性的重要性
J Cardiovasc Nurs. 2016 May-Jun;31(3):262-6. doi: 10.1097/JCN.0000000000000243.
9
Subacute aortic prosthetic mechanical valve thrombosis complicated with acute coronary syndrome.亚急性主动脉人工机械瓣血栓形成并发急性冠状动脉综合征。
Am J Emerg Med. 2018 Oct;36(10):1924.e1-1924.e3. doi: 10.1016/j.ajem.2018.06.044. Epub 2018 Jun 19.
10
Treatment of mechanical aortic valve thrombosis: fibrinolytic treatment versus surgical intervention: result of eight cases.机械性主动脉瓣血栓形成的治疗：溶栓治疗与手术干预对比：8例病例结果
Innovations (Phila). 2010 Nov;5(6):439-43. doi: 10.1177/155698451000500610.

引用本文的文献

1
A Novel Thrombolytic Regimen for Mechanical Prosthetic Valve Thrombosis in a Patient With Antiphospholipid Syndrome.一种用于抗磷脂综合征患者机械人工瓣膜血栓形成的新型溶栓方案。
Cureus. 2022 Apr 9;14(4):e23979. doi: 10.7759/cureus.23979. eCollection 2022 Apr.

本文引用的文献

1
2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.2017年美国心脏协会/美国心脏病学会对2014年《美国心脏协会/美国心脏病学会瓣膜性心脏病患者管理指南》的重点更新：美国心脏病学会/美国心脏协会临床实践指南工作组报告
Circulation. 2017 Jun 20;135(25):e1159-e1195. doi: 10.1161/CIR.0000000000000503. Epub 2017 Mar 15.
2
Treatment of Prosthetic Valve Thrombosis: Current Evidence and Future Directions.人工瓣膜血栓形成的治疗：当前证据与未来方向
J Clin Med Res. 2015 Dec;7(12):932-6. doi: 10.14740/jocmr2392w. Epub 2015 Oct 23.
3
Ultraslow thrombolytic therapy: A novel strategy in the management of PROsthetic MEchanical valve Thrombosis and the prEdictors of outcomE: The Ultra-slow PROMETEE trial.
超慢速溶栓治疗：人工机械瓣膜血栓管理的新策略及预后预测因素：超慢速PROMETEE试验
Am Heart J. 2015 Aug;170(2):409-18. doi: 10.1016/j.ahj.2015.04.025. Epub 2015 May 2.
4
Antithrombotic and thrombolytic therapy for valvular disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.瓣膜疾病的抗栓和溶栓治疗：抗栓治疗与血栓预防，第 9 版：美国胸科医师学院循证临床实践指南。
Chest. 2012 Feb;141(2 Suppl):e576S-e600S. doi: 10.1378/chest.11-2305.
5
Prognosis after aortic valve replacement with a bioprosthesis: predictions based on meta-analysis and microsimulation.生物人工心脏瓣膜置换术后的预后：基于荟萃分析和微观模拟的预测
Circulation. 2001 Mar 20;103(11):1535-41. doi: 10.1161/01.cir.103.11.1535.